In order to analyze trastuzumab-mediated lysis of HER2-expressing cancer cells by inhibition of HER2 signaling after its homodimerization and ADCC-mediated lysis by FcγRIII (CD16)-expressing cells, such as NK cells or γδ T cells, we applied a RTCA-assay. This evidence concerns the gene ERBB2 and cancer.